e-VEGF-IMMUNO-actu
MENULes anti-angiogéniques bientôt en traitement adjuvant ? Volume 12, issue 1, Mars 2017
Author
1 Université de Bordeaux, Inserm U1218, France
- Key words: VEGF, angiopoïétines, associations thérapeutiques, chimiothérapie adjuvante
- DOI : 10.1684/veg.2017.0073
- Page(s) : 2
- Published in: 2017
Wu et al. Efficacy of cotargeting angiopoietin-2 and the VEGF pathway in the adjuvant postsurgical setting for early breast, colorectal, and renal cancers. Cancer Research 2016; 76: 6988-7000.